ONS-5010 is an investigational ophthalmic formulation of bevacizumab, a vascular endothelial growth factor inhibitor, under development as an intravitreal injection.

The CONNEX program consisted of the randomized, double-blind, placebo-controlled phase 3 CONNEX-1, CONNEX-2, and CONNEX-3 studies ...

Mirikizumab is a humanized immunoglobulin G4 monoclonal antibody that selectively binds to the p19 subunit of human interleukin (IL)-23.

Increased odds of atherosclerotic cardiovascular disease seen in association with CLE and SLE, but not psoriasis.

RELiZORB is a digestive enzyme cartridge designed to hydrolyze fats contained in enteral formulas, mimicking the function of lipase. The Food and Drug Administration (FDA) has expanded the approval of ...

Public water systems with detectable levels of contaminants serve counties with higher proportions of Hispanic residents.

Zoledronate administered at baseline and five years effective for preventing fragility fracture, any fracture, major osteoporotic fracture.